The methylation patterns of the rat prolactin (rPRL) (positions ؊440 to ؊20) and growth hormone (rGH) (positions ؊360 to ؊110) promoters were analyzed by bisulfite genomic sequencing. Two normal tissues, the anterior pituitary and the liver, and three rat pituitary GH 3 cell lines that differ considerably in their abilities to express both genes were tested. High levels of rPRL gene expression were correlated with hypomethylation of the CpG dinucleotides located at positions ؊277 and ؊97, near or within positive cis-acting regulatory elements. For the nine CpG sites analyzed in the rGH promoter, an overall hypomethylation-expression coupling was also observed for the anterior pituitary, the liver, and two of the cell lines. The effect of DNA methylation was tested by measuring the transient expression of the chloramphenicol acetyltransferase reporter gene driven by a regionally methylated rPRL promoter. CpG methylation resulted in a decrease in the activity of the rPRL promoter which was proportional to the number of modified CpG sites. The extent of the inhibition was also found to be dependent on the position of methylated sites. Taken together, these data suggest that site-specific methylation may modulate the action of transcription factors that dictate the tissue-specific expression of the rPRL and rGH genes in vivo.
The methylation patterns of the rat prolactin (rPRL) (positions ؊440 to ؊20) and growth hormone (rGH) (positions ؊360 to ؊110) promoters were analyzed by bisulfite genomic sequencing. Two normal tissues, the anterior pituitary and the liver, and three rat pituitary GH 3 cell lines that differ considerably in their abilities to express both genes were tested. High levels of rPRL gene expression were correlated with hypomethylation of the CpG dinucleotides located at positions ؊277 and ؊97, near or within positive cis-acting regulatory elements. For the nine CpG sites analyzed in the rGH promoter, an overall hypomethylation-expression coupling was also observed for the anterior pituitary, the liver, and two of the cell lines. The effect of DNA methylation was tested by measuring the transient expression of the chloramphenicol acetyltransferase reporter gene driven by a regionally methylated rPRL promoter. CpG methylation resulted in a decrease in the activity of the rPRL promoter which was proportional to the number of modified CpG sites. The extent of the inhibition was also found to be dependent on the position of methylated sites. Taken together, these data suggest that site-specific methylation may modulate the action of transcription factors that dictate the tissue-specific expression of the rPRL and rGH genes in vivo.
In mammals, DNA methylation is believed to ensure the silencing of tissue-specific genes in nonexpressing cells while defined combinations of transcription factors dictate the expression of undermethylated genes in specialized cells (14) . The coexistence of these two mechanisms raises questions about their reciprocal interactions. The rat prolactin (rPRL) and rat growth hormone (rGH) genes belong to the class of tissue-specific genes and, as such, provide models with which to address these questions.
In the anterior pituitary gland (AP), the restricted pattern of expression of the rPRL and rGH genes is determined by the presence of the POU homeodomain transcription factor Pit-1/GHF-1 (2, 42, 45, 56) . Multiple cis-acting elements that bind Pit-1 in the promoter regions of both genes have been characterized (45) . Additional factors acting in combination with Pit-1 are required for the selective activation of the rPRL and rGH genes in two related cell types, the lactotropes and somatotropes, respectively. The estrogen receptor, the octamerbinding protein Oct-1, and the recently identified LIM homeodomain protein P-Lim/mLIM-3 are potential cofactors for the tissue-specific expression of the rPRL gene (1, 13, 29, 62, 64, 71) . Likewise, the T3 receptor, the zinc finger protein Zn-15, and the ubiquitous transcription factor Sp1 appear to cooperate with Pit-1 with regard to expression of the rGH gene (19, 41, 61 ; for a review, see reference 69). In addition, Pit-1 participates in the protein kinase A (PKA)-and PKC-mediated regulation of both the rPRL and the rGH genes (22, 48, 53 ; reviewed in references 20 and 69).
The importance of DNA methylation in the regulation of rPRL and rGH gene expression has been far less explored. Nonetheless, all studies revealed an inverse coupling between CpG methylation and rPRL and rGH gene expression, in AP cell lines as well as in normal tissues. This conclusion was drawn from investigations that combined DNA methylation analysis and gene reactivation by the DNA-demethylating agent 5-azacytidine (10, 36, 72) . In all cases, methylation patterns were assessed by Southern blot analyses, following action of methylation-sensitive endonucleases which targeted only a small proportion of CpG sites. As a result, the methylation states of the CpG sites lying within or in the vicinity of cisregulatory elements that bind the transcription factors cited above are unknown. Evaluation of the methylation states of such sites would be of critical interest, since it is believed that DNA methylation inhibits gene expression by altering the binding of transcription factors.
By means of genomic sequencing, several groups have indeed presented evidence linking site-specific methylation in promoter regions and transcriptional inactivity (54, 58) . However, the great majority of the data collected concerns GC-rich and TATA-less promoters (11) and 5Ј upstream regions of X-linked housekeeping genes that are associated with CpG islands (7, 26, 50, 51) . The implication of promoter methylation in gene regulation is further supported by results from functional analyses performed by transfection assays. Reporter gene constructs that are artificially methylated and introduced into cultured cells display an inhibited level of transcription (for a review, see reference 14) . Methylation within the preinitiation domain exhibits the strongest correlation with repression of transcription (38) . However, the inhibition of promoter activity is also proportional to the extent of CpG methylation (9, 27, 32) , and modification of coding (33) or vector (32, 52) sequences is effective as well. Hence, it would be useful to analyze the functional role of promoter methylation regarding tissue-specific gene expression.
As in many, but not all, tissue-specific genes, the promoter regions of the rPRL and rGH genes exhibit rather low GC contents (38% for rPRL and 51% for rGH) and contain a TATA box. Furthermore, the consensus sequence for Pit-1 binding is AT rich (16) . Therefore, it is not at all self-evident that the mechanisms whereby DNA methylation operates on such genes are similar to those preventing transcription of genes with GC-rich and TATA-less promoters (5) . Thus, the aim of this study was to structurally and functionally investigate CpG methylation in relation to the positions of well-characterized regulatory elements in the rPRL and rGH promoters. First of all, we analyzed the occurrence of CpG methylation in all four CpG sites of the proximal rPRL promoter, located between positions Ϫ440 and Ϫ20, and in nine CpG sites of the rGH promoter, located between positions Ϫ360 and Ϫ110 (Fig. 1 ). This analysis was performed by genomic sequencing of bisulfite-treated DNA extracted from different rat pituitary GH 3 cell lines (21, 35, 36, 47) according to the method of Frommer et al. (18) . The tumor-derived cell lines are of great interest, since they differ in their levels of rPRL and rGH mRNAs by several orders of magnitude while expressing equivalent amounts of the Pit-1 protein. Furthermore, they also display similar abilities to express a transfected rPRL promoter-chloramphenicol acetyltransferase (CAT) construct (47) . The same analysis was also performed on DNA originating from the AP and the liver, in which rPRL and rGH gene expression is high or not detectable, respectively (28) . Second, we performed a functional study by selectively methylating either the entire rPRL promoter or its distal or its proximal region before insertion in a CAT expression vector used in a transient-transfection assay.
MATERIALS AND METHODS
Cell lines, culture conditions, and measurement of rPRL and rGH mRNA levels. The cell lines used all originated from the GH 3 tumor-derived cell line (21) . They were obtained in this laboratory by subcloning (GH 3 B 6 ) or selected by alteration of culture conditions (GH 3 CDL) and action of the demethylating agent 5-azacytidine (GH 3 AZA 3 ) (8, 21, 36, 47) . Levels of rPRL and rGH mRNAs were measured by dot blot assay, using a 32 P-labeled cDNA probe as described by Laverrière et al. (37) . The number of mRNA copies per cell was calculated by assuming 15 pg of total RNA per cell.
DNA isolation and bisulfite treatment of genomic DNA. Genomic DNA was prepared as described by Laverrière et al. (36) and Sambrook et al. (59) . Bisulfite treatment was performed by the method described by Frommer et al. (18) , as modified by Clark et al. and Feil et al. (12, 17) . As a control for the full and specific conversion of cytosines to uracils, we sequenced bisulfite-treated and PCR-amplified pPRL-CAT plasmids, either native or in vitro methylated. The results presented here were obtained by analyzing five independent series of bisulfite treatments, all yielding comparable results.
PCR amplifications. Amplifications were performed with 100-l reaction mixtures containing 10 l of bisulfite-treated DNA, as described by Frommer et al. (18) , in the presence of 0.6 U of Taq polymerase (Appligene, Illkirch, France), using a Crocodile II thermocycler (Appligene). The amplification procedure consisted of 2 min of denaturation at 94ЊC followed by 30 to 45 cycles at 94ЊC (1 min), 55ЊC (2 min), and 72ЊC (3 min), ending with 7 min of extension at 72ЊC. All oligodesoxynucleotides were obtained from Eurogentec (Sart Tilman, Belgium). For amplification of the bisulfite-modified top and bottom strands of the rPRL promoter, we designed the primer set P1 and P2 and the primer set P3 and P4, respectively, as follows: P1, 5Ј-TGAAGTTAATATATTTTGGTATTTAGT GGA-3Ј; P2, 5Ј-CCACTACTTTCTCATCTACAAACATTAACT-3Ј; P3, 5Ј-TTACATTTTTAAATTAAAATCAACATACCT-3Ј; and P4, 5Ј-AATTATT GTTTTTTTATTTGTAGATATTGA-3Ј.
The bisulfite-modified top and bottom strands of the rGH promoter were amplified with the primer set G1 and G2 and the primer set G3 and G4, respectively, as follows: G1, 5Ј-AAATTAAGAGGAATAAGATATTATGGGG A-3Ј; G2, 5Ј-CATAACTAAAACCACTAACAACTTATACTA-3Ј; G3, 5Ј-TTG GAGTTATTGATAGTTTGTGTTGATGGA-3Ј; and G4, 5Ј-AATTACCTTCT AATCCCTACATATACACAC-3Ј. None of the original sequences corresponding to the primers contained CpG dinucleotides.
Cloning of PCR products and sequencing. Amplified DNA was purified by gel electrophoresis and cloned into a pGEM-T vector (Promega, Charbonnière, France). Sequences were obtained from double-stranded plasmid templates by using the thermal cycle sequencing method with the same primers used for PCR (65) . The amplified fragments were resolved on 6 or 7% Hydrolink Long Ranger denaturing gels as recommended by the supplier (Bioprobe Systems, Montreuil, France). Vacuum-dried gels were exposed to Kodak X-Omat AR films without an intensifying screen for 4 to 24 h at room temperature. Nine to 34 clones were sequenced per DNA strand, corresponding to a total of 462 clones.
Plasmid constructions and in vitro DNA methylation. The p0.4kbPRL-CAT plasmid has been described previously (46) and contains the proximal rPRL promoter (positions Ϫ427 to ϩ36) inserted between the HindIII and XbaI sites of the multiple cloning site of the pCAT-Basic vector (Promega). The pGEMPRL-CAT expression vector contains the 2-kb rPRL promoter and was designed specifically for selective methylation of promoter sequences. The HindIII site located at position Ϫ427 in the 2-kb upstream sequence of the rPRL promoter was replaced by an NheI site and inserted into the pGEM3Zf(Ϫ) vector between the HindIII and BamHI sites located in the polylinker region together with the CAT-simian virus 40 region originating from the pCAT-Basic vector. The resulting construct contained three unique restriction sites (HindIII, NheI, and XbaI) delimiting the distal region (positions Ϫ1973 to Ϫ427) and proximal region (positions Ϫ427 to ϩ36) of the rPRL promoter. It displayed the same activity in a transient-transfection assay as the pPRL-CAT expression vector kindly provided by C. Bancroft (47) .
In the first set of experiments, the whole constructs were methylated by using either HpaII methylase (M ⅐ HpaII), HhaI methylase (M ⅐ HhaI), or SssI methylase (M ⅐ SssI) (2 U/g of DNA, 2 h at 37ЊC) (New England Biolabs). Completion of methylation was checked by HpaII or HhaI digestion. Mock-methylated constructs were obtained by treating plasmids in the absence of methylase. In a second series of experiments, the pGEMPRL-CAT or the p0.4kbPRL-CAT construct was regionally methylated. DNA fragments corresponding to the entire (positions Ϫ1973 to ϩ36), distal (positions Ϫ1973 to Ϫ427), or proximal (positions Ϫ427 to ϩ36) rPRL promoter region were excised by restriction enzyme digestions. DNA fragments were then purified by gel electrophoresis and methylated at all CpG sites with M ⅐ SssI (10 U/l, 2 U/g of DNA, 2 h at 37ЊC), or mock methylated. M ⅐ SssI was then inactivated at 65ЊC for 15 min, and methylation in the entire or distal rPRL promoter was checked by HhaI digestion. pGEMPRL-CAT and p0.4kbPRL-CAT were then reconstituted by ligation of the promoter with the unmethylated plasmid DNA fragment and purified by phenol-chloroform extraction and ethanol precipitation. The plasmid concentrations were determined by measuring the A 260 .
Transfection. GH 3 AZA 3 cells were transiently transfected by electroporation as previously described (47) Statistics. Statistical comparisons between methylation patterns obtained by genomic sequencing were performed by using the two-sided test of exact probabilities in 2 ϫ 2 contingency tables (66) . The confidence levels used were 95 and 99%, indicated by P Ͻ 0.05 and P Ͻ 0.01, respectively. For transfection experiments, statistical analyses were performed by one-way analysis of variance followed by Fisher's test.
RESULTS
The characteristics of the GH 3 cell lines used have been described previously (35, 36, 47) . The constitutive levels of rPRL and rGH mRNAs were nevertheless reevaluated here in two independent experiments by dot blotting analysis, using cells grown under serum-free culture conditions. The GH 3 CDL cells contained limited amounts of both rPRL and rGH mRNAs (Ϸ50 copies per cell). The GH 3 AZA 3 cell variant (47) expressed increased contents of rPRL mRNA (Ϸ400 copies per cell) and rGH mRNA (Ϸ1,700 copies per cell). Finally, the GH 3 B 6 cells produced considerable amounts of rPRL mRNA (Ϸ7,000 copies per cell) and rGH mRNA (Ϸ6,000 copies per cell).
Genomic sequencing revealed that the CpG located at position Ϫ36 in the rPRL promoter sequence of the SpragueDawley rat strain was replaced by a CpT in that of the WistarFurth strain from which cell lines and adult tissues originated. Because of this genetic polymorphism, the rPRL promoter analyses thus concerned only four CpG sites, located at positions Ϫ373, Ϫ277, Ϫ252, and Ϫ97.
Methylation of the proximal rPRL promoter in GH 3 cell lines. The analysis of GH 3 B 6 DNA showed a virtual absence of unconverted cytosine at all four CpG sites, in a total of 12 and 21 clones analyzed for the top and bottom strand, respectively (data not shown). This observation indicated that the proximal rPRL promoter was extensively unmethylated in GH 3 B 6 cells, which express the rPRL gene at a high level. By contrast, analysis of genomic DNA extracted from GH 3 CDL and GH 3 cells revealed that their promoter sequences were both methylated. Unexpectedly, methylation patterns were found to be highly heterogeneous, as illustrated by the three examples shown in Fig. 2 (lanes C1 to C3) . Furthermore, the 16 (2 4 ) theoretical patterns generated by the combination of methylated and unmethylated CpG sites were actually observed among the 235 clones analyzed, which included those derived from normal tissues (not illustrated). Facing this diversity, we performed statistical comparisons between the top and the bottom strand to determine whether the methylation of CpG sites was symmetrical in each type of DNA. In GH 3 CDL cells, the top strand was less methylated than the bottom strand at FIG. 1. Genomic sequencing strategy for CpG sites and regulatory elements in the rPRL (A) and rGH (B) promoters. CpG dinucleotides and their locations (vertical lines on top and bottom strands with numbers) and the positions of the four sets of primers used for PCR amplification following bisulfite modifications of DNA (arrows) are indicated. The coding, or sense, strands of the rPRL and rGH promoters were amplified with primer set P1 and P2 and primer set G1 and G2, respectively, and referred to as the top strand in the text. Alternatively, the noncoding, or antisense, strands were amplified with primer set P3 and P4 and primer set G3 and G4, respectively, and referred to as the bottom strand in the text. Boxes symbolize the locations of regulatory elements indicated below. cis-acting elements are indicated above or below each box with their upstream and downstream boundaries and the names of related transcription factors in parentheses. 1P through 4P, Pit-1 or GHF1 binding sites 1 through 4; FP1, footprint 1; LSF-1, lactotrope specific factor 1; BTF, basal transcription factor; RRE, Ras response element (6); TRE, thyroid hormone response element; and NF1, nuclear factor 1.
VOL. 16, 1996 METHYLATION OF rPRL AND rGH PROMOTERS 3247 position Ϫ252 (P Ͻ 0.05). No statistical difference was observed for the other positions in the three DNAs analyzed (11 cases). We could thus conclude that methylation of the rPRL promoter occurred rather symmetrically in GH 3 cell lines. However, despite the heterogeneity of methylation patterns within a given cell line, there were significant differences between cell lines (Fig. 3A) . Statistical comparisons between DNAs were performed with the top and bottom strands considered together because they present overall symmetrical methylation patterns. In GH 3 CDL cells, which express the rPRL gene at a very low level, sites Ϫ373, Ϫ277, and Ϫ97 were more methylated than in GH 3 B 6 cells (P Ͻ 0.01) (Fig. 3A) . The average level of methylation per individual rPRL promoter molecule increased from 0 in GH 3 B 6 cells to 1.7 (i.e., 42.5%) methylated sites in GH 3 CDL cells. The GH 3 AZA 3 DNA displayed a significantly lower methylation level than GH 3 CDL DNA for the sites at positions Ϫ373 (P Ͻ 0.01), Ϫ277 (P Ͻ 0.01), and Ϫ97 (P Ͻ 0.05) (Fig. 3A) , with an average of 1.1 (27.5%) methylated sites per individual molecule. Comparison of GH 3 B 6 and GH 3 AZA 3 rPRL promoter methylation patterns revealed that sites at positions Ϫ277, Ϫ252, and Ϫ97 were significantly more methylated in GH 3 AZA 3 than in GH 3 B 6 DNA (P, Ͻ0.01, Ͻ0.05, and Ͻ0.01, respectively) (Fig. 3A) . These analyses thus demonstrated an inverse correlation between gene expression and promoter methylation in GH3 cell lines.
Methylation of the proximal rPRL promoter in adult tissues.
In contrast to what was observed with the cell lines, a clear-cut asymmetry of methylation patterns was obvious between the top and bottom strands from the AP and the liver, except at site Ϫ373 in the latter (Fig. 3B) . The bottom strands from the AP and liver rPRL promoters were found to be similarly unmethylated while their top counterparts differed, as shown by statistical analysis. The average level of methylation was 2.1 (53%) methylated sites per molecule of rPRL promoter in the liver compared with 1.2 (30%) in the AP, while the percentage of fully unmethylated rPRL promoter molecules was increased from 14% in the liver to 54% in the AP. Levels of methylation at positions Ϫ277 (P Ͻ 0.05) and Ϫ97 (P Ͻ 0.01) were significantly lower in the AP than in the liver (Fig. 3B) . The methylation status of these CpGs was thus inversely correlated with the level of rPRL gene expression.
Methylation of the rGH promoter in GH 3 cell lines. As already observed for the rPRL promoter, the methylation pattern of the rGH promoter was obviously heterogeneous in each of the three cell lines. Six clones derived from the rGH promoter of GH 3 B 6 cells displayed six different methylation patterns. Similarly, five clones derived from GH 3 CDL cells showed five distinct methylation patterns (Fig. 4) . With nine CpG sites, there were 512 ( 2 9 ) theoretical methylation patterns. Among the 227 clones analyzed, including those derived from normal tissues, 63 different methylation patterns were actually observed. Nevertheless, statistical comparisons indicated that the methylation patterns of top and bottom strands were symmetrical in DNAs from GH 3 B 6 and GH 3 AZA 3 cells. This contrasted with the asymmetry existing between the top and bottom strands in DNA from GH 3 CDL cells at sites Ϫ200 (P Ͻ 0.01), Ϫ197 (P Ͻ 0.01), Ϫ174 (P Ͻ 0.05), Ϫ149 (P Ͻ 0.05), and Ϫ147 (P Ͻ 0.01). Despite this diversity and similarly to what was observed for the rPRL promoter, significant differences between cell lines were detected at individual CpG sites. The analysis of the rGH promoter from GH 3 B 6 cells, the most active of the three cell lines, revealed an elevated average methylation level of 4.8 (53.3%) methylated sites per molecule. This value was unexpectedly the highest observed and was close to that found for DNA from GH 3 CDL cells (4.1 [45.5%] methylated sites per molecule), the cell line with the lowest level of expression. The GH 3 AZA 3 rGH promoter exhibited the lowest methylation level, with an average of 2.4 (26.7%) methylated sites per molecule. The whole analysis is summarized in Fig. 5A . As for the rPRL promoter, statistical comparisons between DNAs were performed by considering the top and bottom strands together. The three sites located at positions Ϫ335, Ϫ319, and Ϫ231 were found significantly more methylated in GH 3 B 6 than in GH 3 CDL DNA (P, Ͻ0.01, Ͻ0.05, and Ͻ0.01, respectively). This result revealed that hypermethylation of these CpG sites was compatible with a high level of rGH expression. Conversely, the comparison of GH 3 CDL and GH 3 AZA 3 DNAs showed that lower levels of methylation at positions Ϫ319, Ϫ231, Ϫ200, Ϫ197, and Ϫ149 (P, Ͻ0.01, Ͻ0.05, Ͻ0.01, Ͻ0.05, and Ͻ0.01, respectively) coincided with higher levels of rGH gene expression. Furthermore, the proportion of fully unmethylated rGH promoter molecules increased from 7 of 52 in GH 3 CDL DNA to 17 of 52 in GH 3 AZA 3 DNA. Methylation of the rGH promoter in adult tissues. Unlike the rPRL promoter, the top and bottom DNA strands of the rGH promoter displayed symmetrical methylation patterns in the two normal tissues analyzed (Fig. 5B) . As expected from the lack of rGH gene expression, the liver promoter was almost completely methylated, with an average of 7.4 (82.2%) methylated sites per molecule. This value contrasted with the average level of methylation found in AP DNA of 3.2 (36%) methylated sites per molecule (Fig. 5B) . In addition, statistical comparisons of liver and AP methylation patterns, performed by considering the top and bottom strands together, indicated that all nine CpG sites were significantly less methylated in AP DNA (P Ͻ 0.01). Furthermore, the proportion of fully unmethylated molecules increased from 3% in the liver to 36% in the AP.
Altogether, these results and those regarding the rPRL gene have established an inverse relation between methylation of promoter sequences and levels of gene expression in five of the six situations analyzed.
Regional methylation of the rPRL-CAT reporter gene. We then performed experiments to evaluate the functional role of promoter methylation in gene expression, limiting our analysis to the rPRL gene. For this, we designed the expression vector pGEMPRL-CAT (see Materials and Methods and Fig. 6 ). The influence of methylation was monitored by transfecting constructs into GH 3 AZA 3 cells thereafter cultured for 48 h under control conditions or treated with TF (1 M forskolin and 16 nM tetradecanoyl phorbol acetate [TPA]).
Methylation of specified regions of the promoter resulted in various levels of reporter gene expression (Fig. 7, constructs The responsiveness of the proximal promoter thus differed from that of the distal or entire promoter, in which methylation altered in parallel constitutive and TF-stimulated expression.
To determine whether methylation in the region surrounding the rPRL promoter might also be efficient in regulating gene expression, we methylated the pGEMPRL-CAT plasmid, using either M ⅐ HpaII or M ⅐ HhaI. The resulting constructs contained CpG sites lying in vector sequences (Fig. 7A , constructs e and f), except for one site located in the distal promoter (construct f). The number of methylated sites (i.e., 16 and 18) was of the same order as in the entire promoter (14 sites). After methylation with M ⅐ HpaII, we observed a small inhibition of CAT expression in untreated cells [(16 Ϯ 3)%] and no significant inhibition in TF-treated cells (Fig. 7B) . By contrast, HhaI-methylated sites yielded a potent inhibition of CAT activity, which reached (39 Ϯ 18)% in untreated cells and (44 Ϯ 9)% in TF-treated cells. Finally, after full in vitro methylation by M ⅐ SssI, CAT expression was totally abolished (Fig.  7B, construct g ) (see also reference 47).
Taken together, these results indicated that methylation in promoter sequences and in surrounding regions repressed gene expression. Furthermore, the extent of inhibition appeared to be dependent on both the number of methylated CpG sites and their locations. 
DISCUSSION
To determine the relationship between expression and methylation in the rPRL and rGH genes, we have analyzed the methylation state of several CpG sites within their promoter regions by using bisulfite genomic sequencing. This procedure provides high-resolution data which allow a detailed map of methylated sites to be drawn. Three subclones of pituitary tumor-derived cell lines and two normal tissues, the AP and the liver, which differ in their ability to express the rPRL and rGH genes, were examined. Comparative analyses establish an inverse correlation between the extent of promoter methylation and the level of gene expression in all but one case tested. In addition, we have shown that targeted methylation of rPRL promoter regions yields significant inhibition of reporter genes in transient-transfection assays. Altogether, data obtained by two independent and complementary approaches argue for a key role of CpG methylation in rPRL and rGH promoter activities.
The results obtained from genomic sequencing on CpG sites lying in promoter regions are consistent with previous analyses using HpaII and MspI restriction enzymes in conjunction with Southern blotting (36) . By this method, we observed that the methylation status of three sites in the rPRL gene and of five sites in the rGH gene was correlated with the level of gene expression. Likewise, the methylation status of the rGH gene in the GH 3 B 6 cell line had already appeared as an exception, with the gene being hypermethylated despite a high level of expression. However, a major advance is made here because it becomes possible to correlate the impact of CpG methylated sites with their positions on cis-acting elements crucial for cell-specific and regulated gene expression.
As concerns the rPRL gene, all the cis-acting elements characterized in the proximal region of the promoter are involved in positive regulation. If DNA methylation down-regulates rPRL gene transcription, hypomethylation is expected to correlate with a high level of gene expression. In keeping with this hypothesis, it is significant that specific hypomethylation of CpG sites Ϫ277 and Ϫ97 coincides with a high promoter activity in both GH 3 tumor cells and the normal AP. Furthermore, the increase in rPRL gene expression in GH 3 AZA 3 cells compared with that in GH 3 CDL cells is additionally linked to the demethylation of CpG site Ϫ373. Of note, CpG site Ϫ97 The activities of methylated and mock-methylated constructs obtained by ligation (constructs a through d) were quantified as CAT activity per well. Activities of HpaII-, HhaI-, and SssI-methylated and mock-methylated constructs (e to g) were quantified as CAT/␤-galactosidase activity ratios. Inhibition was calculated as the ratio of (U Ϫ M)/U, where U is the activity of the mock-methylated construct and M is the activity of its corresponding methylated counterpart. Results are the means Ϯ standard deviations for four (constructs b, c, d, and f) or three (construct e) independent transfections and the means Ϯ ranges of two independent experiments (constructs a and g), with each experiment performed in triplicate.
VOL. 16, 1996 METHYLATION OF rPRL AND rGH PROMOTERS 3251 occupies a strategic position: it is located near regulatory elements, including Pit-1, pLim, Oct-1 (positions Ϫ62 to Ϫ38), the LSF-1 binding site (positions Ϫ65 to Ϫ45), and the basal transcription element (BTE) (positions Ϫ117 to Ϫ85) (1, 23, 29, 45, 62, 71) . In addition, this particular CpG lies in the cyclic AMP (cAMP)-like response element (CLE) (positions Ϫ100 to Ϫ85), which mediates not only cAMP-stimulated but also TPA-stimulated regulation (40) . Significantly, a CpG is present at the same position in the PRL promoter sequences of two other rat strains (Sprague-Dawley and Hooded) and of bovine and human species. Altogether, these data underline the probable importance of this CpG site in the regulation of PRL gene expression. Similar to the rPRL promoter, the rGH promoter contains cis-acting elements implicated in positive regulation. However, it also possesses negative regulatory elements, such as silencer 1 and the proximal repressive element (PRE), which serve repressive functions (34, 49, 57) . In this context, hypomethylation of positive regulatory sequences as well as hypermethylation of negative regulatory sequences may result in a high level of rGH gene expression. In GH 3 AZA 3 cells, compared with GH 3 CDL cells, a higher level of gene expression was correlated with hypomethylation of five CpG sites. Four of these sites, located at positions Ϫ231, Ϫ200, Ϫ197, and Ϫ149, are situated inside or near cis-acting elements which bind positive regulatory factors, such as growth hormone factor 3 (GHF3), T 3 receptor, Pit-1, GHF2, and SP1 (19, 45, 61) . Conversely, the site located at position Ϫ319 lies inside the negative regulatory element termed silencer 1. In the AP, all sites are hypomethylated compared with those in the liver. Consequently, the high level of rGH gene expression appears to be correlated with the hypomethylation of four additional sites that lie inside or in the vicinity of positive (CpG sites Ϫ174 and Ϫ147) or negative (CpG sites Ϫ335 and Ϫ168) regulatory sequences. The relatively high level of gene expression in GH 3 B 6 cells correlates with hypermethylation of two sites located near or inside silencer 1 at positions Ϫ335 and Ϫ319 and of one site located on the GHF3 binding site at position Ϫ231. Thus, no simple correlation can be established between high levels of rGH promoter activity and the methylation of positive and/or negative cis-acting elements. Additional parameters, such as unequal sensitivity of transcription factors regarding DNA methylation and/or differential distribution of transcription factors among cell lines, should be considered to account for the present observation.
However, data obtained by genomic sequencing do not provide information regarding the functional relevance of differential methylation at CpG sites. It cannot be excluded that the different methylation patterns are linked to phenotypic modulations unrelated to gene expression. For example, alterations in the activity of factors associated with de novo modification (or demodification), such as DNA methyltransferase, may be responsible for changes in DNA methylation, especially in cell lines (67) . In this respect, regional methylation experiments provide important information. Methylation of the rPRL promoter, which involves only 14 CpG sites dispersed within 2 kb, strongly represses CAT gene expression in transient-transfection experiments. This methylation-induced inhibition affects equally basal and regulated transcription, suggesting that the factors involved in tissue-specific and in PKA-and PKC-stimulated expression, such as Pit-1, are sensitive to CpG methylation. Methylation of the distal part of the rPRL promoter induced a weaker but similarly balanced effect. In contrast, methylation of CpGs lying in the proximal region preferentially decreased the stimulation induced by the activation of PKAand PKC-dependent pathways. These experiments thus revealed a dual feature for DNA methylation. On the one hand, the modification of a limited domain, such as in the case of the proximal 0.4-kb region, may inhibit specialized functions of the DNA sequence by preventing directly the binding of particular transcription factors, such as those involved in PKA-and PKCmediated regulation of the rPRL gene. This hypothesis is supported by in vitro experiments demonstrating that CpG methylation decreases the binding of transcription factors such as CREB/ATF and AP2 (15) . Of note, the consensus cis-acting sequences of these two factors present homology with the rPRL promoter sequence lying between 1P and 2P binding sites and containing the CpG site Ϫ97. On the other hand, the methylation of extended regions of DNA, such as the 2-kb promoter or its 1.5-kb distal region, may operate by altering overall chromatin structure, thereby influencing gene accessibility. In support of such an indirect mechanism, several proteins that bind preferentially to methylated DNA have been described, namely, methyl-CpG-binding proteins, methylated DNA-binding proteins, and histones belonging to the H1 family (4, 30, 31, 39, 43, 60 ; for a review, see reference 68). This interpretation is also consistent with the fall in CAT activity observed in HhaI-methylated constructs. With the exception of one site located within the rPRL promoter at position Ϫ1231, all HhaI-methylated CpG sites are located in the plasmid sequence. In accordance with the findings of Kass et al. (32) , the multiple sites located in the vicinity of the rPRL promoter might provide a focus of methylation able to induce the formation of inactive chromatin, which in turn may spread to the contiguous unmethylated rPRL promoter. The HhaI site located in the rPRL distal region may provide an additional seeding point for propagating an inactive chromatin structure. Such a spreading was observed 24 to 48 h following transfection, i.e., as under our experimental conditions (32) . Why HpaII methylation seems to be relatively inefficient at inducing a similar phenomenon remains to be elucidated.
A secondary and unexpected finding resulting from genomic sequencing analysis was the heterogeneous nature of the rPRL and rGH promoter methylation profiles in cell lines as well as in normal tissues. This mosaicism may result from unfaithful maintenance of DNA methylation patterns, such as is typically observed in cultured and continuously replicating cells (25, 55) . Mosaic methylation patterns were also observed in clonal, histologically homogeneous tumoral tissue (63) . Moreover, all of the few studies performed by genomic sequencing underline the heterogeneity of the methylation profiles found in tissues and clonal populations of animal cells, as well as in plants (18, 44, 50) . However, the great diversity of patterns observed in the course of the present analysis raises questions about the mechanisms whereby DNA methylation is propagated in cultured cells and in normal tissues.
On the other hand, and as surprising, is the asymmetry observed in the methylation patterns of top and bottom strands of the rPRL promoter in normal tissues. Hemimethylated sites have been described previously, and some of them appear to be maintained during several rounds of cell division (58, 70) . However, it is generally accepted that hemimethylated CpG sites are efficiently methylated by the maintenance methylase following DNA replication (reviewed in reference 24). Moreover, the rGH promoter displays symmetric methylation patterns in DNAs from the same origin. This discrepancy between the rPRL and the rGH promoters might be connected to the findings of Borrelli et al. (3) , who demonstrated that PRL expression and lactotrope differentiation are postmitotic events, in contrast to GH expression and somatotrope differentiation. In keeping with this idea, the hypothetical setting of a rPRL promoter methylation pattern might be a postmitotic phenomenon in normal tissues, in which cell division occurs unfrequently compared with that in tumor cells. This might explain why the rPRL promoter is not hemimethylated in GH 3 cell lines, in which the doubling time is Ϸ40 h. According to the same hypothesis, the establishment of an rGH promoter methylation pattern in differentiating cells would occur before entry of the cells into the postmitotic phase, leading to symmetrical modification of both strands, as actually observed in normal tissues as well as in tumor cells.
In keeping with this idea, it would be crucial to characterize the methylation patterns of the rGH and rPRL promoters from early to late stages of pituitary ontogenesis. Such knowledge should provide important clues in the understanding of the interplay between DNA methylation and the complex network of transcription factors suspected to govern lactotrope and somatotrope cell differentiation or to be involved in the maintenance of their differentiated state.
